Flavia Matovu Kiweewa is a physician currently working as a Senior Research Scientist/ Investigator with MU-JHU Care Ltd, an Honorary Lecturer with Makerere University School of Public Health in Kampala- Uganda, and a concluding Ph.D. Fellow at the Wits School of Public Health, South Africa.
She was the site lead investigator at the highest enrolling site of the groundbreaking MTN-020/ASPIRE study, a phase III microbicide trial protocol evaluating the ‘’Safety and Effectiveness of a Vaginal Matrix Ring Containing Dapivirine for the Prevention of HIV-1 Infection in Women’’. She is a Principal Investigator on an NIH sponsored R01 in bone health. She is also leading an Investigator sponsored Phase IV trial with the overall goal of optimizing bone health in HIV infected women.
More recently, she received the 2019/ 2020 prestigious Gilead Global Public Health Award in Viral Hepatitis, a grant that’s evaluating perinatal outcomes among HIV infected women co-infected with hepatitis B (HBV).